Hi Steve
normally I dislike replying down this direction and I only answer because its you. I dislike the way that the discussions soon turn to a defensive posturing of choice as if there was any attack on choice to begin with.
epstns;n866117 said:
pellicle - I read the abstract of the article, and for its time I'm sure it was good information. I wonder, though, what the newer generations of tissue valves are like...
its a good question. Firstly it was intented as an answer to a question to start the asker thinking about the issues and the known situation. As one who has some background in materials science (and I mean you) you'll know that materials do not really change so fast. Sure there is advertising but then we both know that from discovery of issue -> to fomulation of a materials -> to passing testing -> to making the market is not something which happens in weeks, and I'd say 10 years is not a bad estimate.
The valves studied/analyzed for the article would have been a generation or two earlier than tigerlily's and my valves, which are supposed to have superior life expectancies. Of course, we won't know anything about these "third generation" valves for a number of years yet.
worse, I suspect we won't know much because as research is increasingly privately funded (not publicly funded) there is not only no imperative to publish results but quite the reverse: it becomes a business secret under Intellectual Property protections.
However what we can do is look to see how many of these new generation valves end up here on the form with disturbing stories of early failure. For sure this is not a scientifically valid approach for sampling, but it does provide some information.
Also, the researchers have done some really complicated statistical analysis of the "useful lifespan" of tissue valves, but I don't remember seeing anywhere the minimum and maximum ages of valves in their cohort. In other words, they will publish the mean and average useful lives of valves, but won't admit how soon some fail or how long some can last.
exactly ... because (as you will know) its like asking how long is a piece of string.
Should we expect that newer valves last longer? Well is that a criteria for the maker? Is the maker of the view that 15 years is sufficient and that the expence of longer lasting valves may prohibit their cost. Especially when you consider that there already exists a valve type that is made and proven to last quite well (although bringing with it other issues). I have a 1989 Pajero that did 400,000Km on the engine before I had to do a rebuild. Will I get that long from a new one? Will I get longer? I doubt it because the market no longer values that.
I think that the answer to this lies in a step back and re-assessing things from a different standpoint. When we have a valve replacement we exchange "valvular heart disease" for "prosthetic valve disease". This is an important recognition (and it is the manner in which the medical profession views this). One can be managed, the other can not.
We know that valvular heart disease progresses rapidly after levels of degeneration of the valve is reached. We know that death follows that without intervention. So when making a choice to avoid death we have to pick which type of management we wish to undertake. That is the real choice that the patient makes when choosing tissue or mechanical prosthetic.